Monoclonal antibody therapy for meningioma, illustration - Stock-Grafiken

Illustration of monoclonal antibody (blue and orange) therapy for meningioma (pink). Meningiomas are benign (non-cancerous) tumours that arise from the meninges, the membranes that surround the brain. Monoclonal antibodies (mAbs) are proteins secreted by a cloned line of cells that have been engineered to respond to a particular target